FDA Inspection 1010010 — David S. Rosenberg, MD
The FDA completed an inspection of David S. Rosenberg, MD on April 21, 2017 in Florissant, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 21, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Florissant, MO (United States)
Additional Details
Clinical Investigator (CI)